Hikma Pharmaceuticals Statistics

Total Valuation

Hikma Pharmaceuticals has a market cap or net worth of GBP 4.14 billion. The enterprise value is 4.91 billion.

Market Cap	4.14B
Enterprise Value	4.91B

Important Dates

The next estimated earnings date is Thursday, August 8, 2024.

Earnings Date	Aug 8, 2024
Ex-Dividend Date	Mar 21, 2024

Share Statistics

Hikma Pharmaceuticals has 221.89 million shares outstanding. The number of shares has decreased by -1.13% in one year.

Shares Outstanding	221.89M
Shares Change (YoY)	-1.13%
Shares Change (QoQ)	+0.33%
Owned by Insiders (%)	2.25%
Owned by Institutions (%)	54.28%
Float	155.23M

Valuation Ratios

The trailing PE ratio is 27.98 and the forward PE ratio is 11.58. Hikma Pharmaceuticals's PEG ratio is 2.47.

PE Ratio	27.98
Forward PE	11.58
PS Ratio	1.83
PB Ratio	2.39
P/FCF Ratio	12.02
PEG Ratio	2.47

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.73, with an EV/FCF ratio of 14.24.

EV / Earnings	32.89
EV / Sales	2.17
EV / EBITDA	7.73
EV / EBIT	10.10
EV / FCF	14.24

Financial Position

The company has a current ratio of 1.57, with a Debt / Equity ratio of 53.92.

Current Ratio	1.57
Quick Ratio	0.82
Debt / Equity	53.92
Debt / EBITDA	1.47
Debt / FCF	2.71
Interest Coverage	8.48

Financial Efficiency

Return on equity (ROE) is 8.81% and return on invested capital (ROIC) is 11.33%.

Return on Equity (ROE)	8.81%
Return on Assets (ROA)	8.46%
Return on Capital (ROIC)	11.33%
Revenue Per Employee	248,034
Profits Per Employee	16,392
Employee Count	9,100
Asset Turnover	0.63
Inventory Turnover	1.76

Taxes

In the past 12 months, Hikma Pharmaceuticals has paid 68.92 million in taxes.

Income Tax	68.92M
Effective Tax Rate	31.90%

Stock Price Statistics

The stock price has increased by +1.87% in the last 52 weeks. The beta is 0.40, so Hikma Pharmaceuticals's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	+1.87%
50-Day Moving Average	1,928.40
200-Day Moving Average	1,892.13
Relative Strength Index (RSI)	43.33
Average Volume (20 Days)	333,212

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hikma Pharmaceuticals had revenue of GBP 2.26 billion and earned 149.17 million in profits. Earnings per share was 0.67.

Revenue	2.26B
Gross Profit	1.10B
Operating Income	485.96M
Pretax Income	220.61M
Net Income	149.17M
EBITDA	621.00M
EBIT	485.96M
Earnings Per Share (EPS)	0.67

Full Income Statement

Balance Sheet

The company has 179.78 million in cash and 935.03 million in debt, giving a net cash position of -755.25 million or -3.40 per share.

Cash & Cash Equivalents	179.78M
Total Debt	935.03M
Net Cash	-755.25M
Net Cash Per Share	-3.40
Equity (Book Value)	1.73B
Book Value Per Share	7.81
Working Capital	597.45M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 477.33 million and capital expenditures -132.68 million, giving a free cash flow of 344.65 million.

Operating Cash Flow	477.33M
Capital Expenditures	-132.68M
Free Cash Flow	344.65M
FCF Per Share	1.55

Full Cash Flow Statement

Margins

Gross margin is 48.94%, with operating and profit margins of 21.53% and 6.61%.

Gross Margin	48.94%
Operating Margin	21.53%
Pretax Margin	9.77%
Profit Margin	6.61%
EBITDA Margin	27.51%
EBIT Margin	21.53%
FCF Margin	15.27%

Dividends & Yields

This stock pays an annual dividend of 0.56, which amounts to a dividend yield of 2.99%.

Dividend Per Share	0.56
Dividend Yield	2.99%
Dividend Growth (YoY)	23.02%
Years of Dividend Growth	2
Payout Ratio	72.11%
Buyback Yield	1.13%
Shareholder Yield	4.12%
Earnings Yield	3.57%
FCF Yield	8.32%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a